Cytokinetics Inc. | Key People and Executives
Robert I. Blum
President, Chief Executive Officer & Director
Robert M. Califf
Director
Santo J. Costa
Independent Director
Wendell D. Wierenga
Independent Director
B. Lynne Parshall
Independent Director
John Tannahill Henderson
Independent Director
Sandy D. Smith
Independent Director
Robert I. Blum
President, Chief Executive Officer & Director
Ching Jaw
Chief Financial Officer & Senior Vice President
Andrew A. Wolff
Chief Medical Officer & Senior Vice President
Fady Ibraham Malik
Executive Vice President-Research & Development
Bradley Paul Morgan
Senior VP-Research & Non Clinical Development
Elisabeth A. Schnieders
Senior Vice President-Business Development
Bonnie A. Charpentier
Senior VP-Regulatory Affairs & Compliance
Robert M. Califf
Director
Peter S. Roddy
Chief Accounting Officer & Senior Vice President
Diane Weiser
VP-Corporate Communications & Investor Relations
David W. Cragg
Senior Vice President-Human Resources
Santo J. Costa
Independent Director
Wendell D. Wierenga
Independent Director
B. Lynne Parshall
Independent Director
John Tannahill Henderson
Independent Director
Sandford D. Smith
Independent Director
| Address |
280 East Grand Avenue
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.cytokinetics.com |
| Updated |
07/08/2019 |
| Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA. |
